- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
10 result(s) found for: Lymphoscintigraphy.
Displaying page 1 of 1.
EudraCT Number: 2019-004914-32 | Sponsor Protocol Number: NL71558.041.19 | Start Date*: 2020-03-12 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET-CT | |||||||||||||||||||||||
Medical condition: The IMP will be used for the identification of sentinel lymph nodes in patients with early-stage oral squamous cell carcinoma and a clinically negative neck (T1-3N0M0). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Temporarily Halted) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003554-23 | Sponsor Protocol Number: NL68976.041.19 | Start Date*: 2021-12-03 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: Sentinel lymph node detection in early-stage ORal Cavity squamous cell carcinoma using Magnetic Resonance (MR) lymphogrAphy | |||||||||||||||||||||||
Medical condition: The IMP will be used for the identification of sentinel lymph node(s) in patients with early-stage oral cavity squamous cell carcinoma and a clinically negative neck (T1-3, N0, M0). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002978-13 | Sponsor Protocol Number: Verde_Nano | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | |||||||||||||
Full Title: Assessment of the feasibility and clinical efficacy of the ICG - 99mTc - nanocolloid for sentinel lymph node biopsy | |||||||||||||
Medical condition: Patients with breast cancer or melanoma candidates for sentinel node biopsy surgery. The regional lymph nodes are the most common site of metastatic involvement in patients with cutaneous melanoma ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005546-42 | Sponsor Protocol Number: MELISA | Start Date*: 2021-06-21 | |||||||||||
Sponsor Name:Fundacio Clinic per a la Recerca Biomedica | |||||||||||||
Full Title: Sentinel lymph node assessment in ovarian cancer. Lymphatic mapping with two tracers and intraoperative lymphoscintigraphy. | |||||||||||||
Medical condition: Sentinel lymph node in ovarian cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000604-25 | Sponsor Protocol Number: R96-A6604-14-S22 | Start Date*: 2015-05-02 |
Sponsor Name:Danish Cancer Society Research Center | ||
Full Title: HBOT LYCA: Hyperbaric Oxygen Therapy to reduce Lymphoedema after Breast Cancer - an explorative clinical trial | ||
Medical condition: breast cancer related lymphedema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004389-33 | Sponsor Protocol Number: 5063562 | Start Date*: 2020-07-10 | |||||||||||||||||||||
Sponsor Name:Olli Lahtinen | |||||||||||||||||||||||
Full Title: Contrast enhanced ultrasound a novel technique in lymphatic imaging – A Prospective study | |||||||||||||||||||||||
Medical condition: | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014823-22 | Sponsor Protocol Number: LISER-M | Start Date*: 2009-07-28 | |||||||||||
Sponsor Name:AZIENDA USL DI FORLI` | |||||||||||||
Full Title: Second biopsy of axillary sentinel node in the local recurrence of breast cancer after mastectomy and first negative sentinel node. Studio LiSeR - M | |||||||||||||
Medical condition: patients with first local recurrence of breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004443-20 | Sponsor Protocol Number: HP-LY-CL-2063 | Start Date*: 2018-05-07 | |||||||||||||||||||||
Sponsor Name:Herantis Pharma Plc | |||||||||||||||||||||||
Full Title: A Phase II, double-blind, placebo-controlled, randomized study to assess the efficacy, safety and tolerability of Lymfactin® (AdAptVEGF-C Adenoviral Vector) in combination with a surgical lymph nod... | |||||||||||||||||||||||
Medical condition: Secondary lymphedema associated with the treatment of breast cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000397-29 | Sponsor Protocol Number: S63212 | Start Date*: 2021-06-08 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: KCE-191245: Comparison of reconstructive surgery versus no surgery, additional to decongestive lymphatic therapy (usual care), for the treatment of lymphoedema, through a multicentre, pragmatic ran... | ||
Medical condition: Primary or secondary lymphoedema of upper or lower limb | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000677-23 | Sponsor Protocol Number: CLCL161A2201 | Start Date*: 2012-10-24 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A Phase II, multi-center, open-label, neoadjuvant, randomized study of weekly paclitaxel with or without LCL161 in patients with triple negative breast cancer | ||
Medical condition: Triple negative breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) ES (Completed) IE (Completed) IT (Completed) BE (Completed) CZ (Completed) DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.